Bharat Serums to set up Rs 200 crore injectables facility in Hyderabad

Bharat Serums and Vaccines Limited (BSV) is investing 200 crore to establish a speciality injectables manufacturing facility in Hyderabad's Genome Valley. The facility, which will be built on a 10-acre land parcel, is expected to be ready for production by 2026. The facility will manufacture women's health products, emergency products, immunoglobulins, hormones, and vaccines. It will significantly increase BSV's injectables capacity. The company currently has manufacturing facilities in Maharashtra and Germany.